Harbour Investments’s Collegium Pharmaceutical COLL Stock Holding History

Harbour Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.57K	Hold	99	–	–	﹤0.01%	3821
2026 Q1	$3.3K	Buy	99 +9	+10%	+$381	﹤0.01%	3751
2025 Q4	$4.17K	Sell	90 -90	-50%	-$3.77K	﹤0.01%	3077
2025 Q3	$6.3K	Hold	180	–	–	﹤0.01%	2894
2025 Q2	$5.32K	Hold	180	–	–	﹤0.01%	2853
2025 Q1	$5.37K	Hold	180	–	–	﹤0.01%	2799
2024 Q4	$5.16K	Hold	180	–	–	﹤0.01%	2712
2024 Q3	$6.96K	Buy	+180	New	+$6.42K	﹤0.01%	2506
2021 Q2	–	Sell	-429	Closed	-$10K	–	3790
2021 Q1	$10K	Buy	+429	New	+$10.2K	﹤0.01%	2595

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Harbour Investments's COLL Position: Q2 2026 in Review

Harbour Investments held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 99 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

Harbour Investments first reported a position in COLL in Q1 2021 and has held it in 9 quarters since. The position peaked at $10K in Q1 2021. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Harbour Investments held 99 shares of Collegium Pharmaceutical worth $3.57K as of Q2 2026.
Harbour Investments left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3821 holding.
Harbour Investments first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 9 quarters since.
Harbour Investments's Collegium Pharmaceutical position peaked at $10K in Q1 2021.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.